These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28038383)

  • 21. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.
    Qiu MK; Wang SC; Dai YX; Wang SQ; Ou JM; Quan ZW
    PLoS One; 2015; 10(6):e0128523. PubMed ID: 26035207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
    Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
    Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
    J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
    Gao X; Zhu Y; Li G; Huang H; Zhang G; Wang F; Sun J; Yang Q; Zhang X; Lu B
    PLoS One; 2012; 7(2):e30676. PubMed ID: 22363469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3
    Zhang T; Ren T; Song Z; Zhao J; Jiao L; Zhang Z; He J; Liu X; Qiu L; Li L; Zhou S; Meng B; Zhai Q; Ren X; Qian Z; Wang X; Zhang H
    J Immunol Res; 2020; 2020():6968595. PubMed ID: 33178839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated expression of Tim-3 on CD8 T cells correlates with disease severity of pulmonary tuberculosis.
    Wang X; Cao Z; Jiang J; Li Y; Dong M; Ostrowski M; Cheng X
    J Infect; 2011 Apr; 62(4):292-300. PubMed ID: 21382414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models.
    Ma S; Tian Y; Peng J; Chen C; Peng X; Zhao F; Li Z; Li M; Zhao F; Sheng X; Zong R; Li Y; Zhang J; Yu M; Zhu Q; Tian X; Li Y; Neckenig MR; Liu H; Zhan P; Yue X; Wu Z; Gao L; Liang X; Liu X; Li C; Ma C
    Sci Transl Med; 2023 Nov; 15(722):eadg6752. PubMed ID: 37967204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer.
    Kuai W; Xu X; Yan J; Zhao W; Li Y; Wang B; Yuan N; Li Z; Jia Y
    Biomed Res Int; 2020; 2020():5294043. PubMed ID: 32509862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression.
    Dong J; Cheng L; Zhao M; Pan X; Feng Z; Wang D
    Tumour Biol; 2017 May; 39(5):1010428317701651. PubMed ID: 28466780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity.
    Rahimi A; Hossein-Nataj H; Hajheydari Z; Aryanian Z; Shayannia A; Ajami A; Asgarian-Omran H
    Exp Dermatol; 2019 Jun; 28(6):674-681. PubMed ID: 31046170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer.
    Kang CW; Dutta A; Chang LY; Mahalingam J; Lin YC; Chiang JM; Hsu CY; Huang CT; Su WT; Chu YY; Lin CY
    Sci Rep; 2015 Oct; 5():15659. PubMed ID: 26493689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tim-3 and Tim-4 as the potential targets for antitumor therapy.
    Cheng L; Ruan Z
    Hum Vaccin Immunother; 2015; 11(10):2458-62. PubMed ID: 26211834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.
    Lee KA; Shin KS; Kim GY; Song YC; Bae EA; Kim IK; Koh CH; Kang CY
    Aging Cell; 2016 Apr; 15(2):291-300. PubMed ID: 26750587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
    Cheng G; Li M; Wu J; Ji M; Fang C; Shi H; Zhu D; Chen L; Zhao J; Shi L; Xu B; Zheng X; Wu C; Jiang J
    Int J Clin Exp Pathol; 2015; 8(8):9452-7. PubMed ID: 26464703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer.
    Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X
    Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma.
    Cai C; Zhang J; Li M; Wu ZJ; Song KH; Zhan TW; Wang LH; Sun YH
    Tumour Biol; 2016 Jun; 37(6):8209-18. PubMed ID: 26715281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CEACAM1 is associated with recurrence after hepatectomy for colorectal liver metastasis.
    Yamaguchi S; Yokoyama S; Ueno M; Hayami S; Mitani Y; Takeuchi A; Shively JE; Yamaue H
    J Surg Res; 2017 Dec; 220():353-362. PubMed ID: 29180203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NK cell expression of Tim-3: First impressions matter.
    So EC; Khaladj-Ghom A; Ji Y; Amin J; Song Y; Burch E; Zhou H; Sun H; Chen S; Bentzen S; Hertzano R; Zhang X; Strome SE
    Immunobiology; 2019 May; 224(3):362-370. PubMed ID: 30876792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.